Bristol Myers Squibb (NYSE:BMY) Falls after FDA Delays Action on Cancer Therapy - TipRanks.com

Pharmaceutical companies Bristol Myers Squibb (NYSE:BMY) and 2seventy bio (TSVT) are down in trading at the time of writing. This comes after announcing that the U.S. Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) will meet to discuss data supporting the…#bristolmyerssquibb #bmy #fda #odac #karmma3 #futureofbmystock #moderatebuy #holds
Source: Reuters: Health - Category: Consumer Health News Source Type: news